Gabriella Mccarty, NP-C

NPI: 1508896754
Total Payments
$140,804
2024 Payments
$72,510
Companies
35
Transactions
541
Medicare Patients
1,552
Medicare Billing
$112,679

Payment Breakdown by Category

Other$65,989 (46.9%)
Travel$33,250 (23.6%)
Consulting$30,301 (21.5%)
Food & Beverage$11,264 (8.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $57,709 64 41.0%
Travel and Lodging $33,250 91 23.6%
Consulting Fee $30,301 29 21.5%
Food and Beverage $11,264 348 8.0%
Honoraria $5,810 6 4.1%
Compensation for serving as faculty or as a speaker for a medical education program $2,470 3 1.8%

Top Paying Companies

Company Total Records Latest Year
Phathom Pharmaceuticals, Inc. $23,636 72 $0 (2024)
PFIZER INC. $20,373 48 $0 (2024)
Lilly USA, LLC $17,663 39 $0 (2024)
E.R. Squibb & Sons, L.L.C. $13,648 29 $0 (2024)
Janssen Biotech, Inc. $10,386 32 $0 (2024)
ABBVIE INC. $9,711 84 $0 (2024)
EVOKE PHARMA, INC. $8,749 18 $0 (2024)
Intercept Pharmaceuticals, Inc. $8,520 31 $0 (2024)
Celgene Corporation $5,621 34 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $5,620 42 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $72,510 232 Phathom Pharmaceuticals, Inc. ($23,279)
2023 $30,227 117 INTERCEPT PHARMACEUTICALS, INC. ($5,110)
2022 $29,341 133 ABBVIE INC. ($6,857)
2021 $8,726 59 E.R. Squibb & Sons, L.L.C. ($3,749)

All Payment Transactions

541 individual payment records from CMS Open Payments — Page 1 of 22

Date Company Product Nature Form Amount Type
12/17/2024 Madrigal Pharmaceuticals REZDIFFRA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $680.00 General
Category: LIVER DISEASE
12/12/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $27.66 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
12/11/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Travel and Lodging Cash or cash equivalent $40.20 General
Category: GASTROENTEROLOGY
12/10/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $51.88 General
Category: GASTROENTEROLOGY
12/06/2024 Phathom Pharmaceuticals, Inc. Travel and Lodging In-kind items and services $1,184.60 General
12/06/2024 Phathom Pharmaceuticals, Inc. Travel and Lodging In-kind items and services $485.95 General
12/06/2024 Phathom Pharmaceuticals, Inc. Travel and Lodging In-kind items and services $203.49 General
12/06/2024 Phathom Pharmaceuticals, Inc. Travel and Lodging In-kind items and services $161.54 General
12/06/2024 Phathom Pharmaceuticals, Inc. Food and Beverage In-kind items and services $81.59 General
12/06/2024 Phathom Pharmaceuticals, Inc. Food and Beverage In-kind items and services $71.31 General
12/06/2024 Phathom Pharmaceuticals, Inc. Food and Beverage In-kind items and services $55.21 General
12/03/2024 QOL Medical, LLC SUCRAID (Drug) Food and Beverage Cash or cash equivalent $27.58 General
Category: THERAPY FOR CSID
11/20/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,025.00 General
Category: GASTROENTEROLOGY
11/20/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Travel and Lodging Cash or cash equivalent $12.86 General
Category: GASTROENTEROLOGY
11/19/2024 Lilly USA, LLC OMVOH (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $600.00 General
Category: Immunology
11/19/2024 Merck Sharp & Dohme LLC DIFICID (Drug) Food and Beverage In-kind items and services $23.93 General
Category: INFECTIOUS DISEASE
11/19/2024 EVOKE PHARMA, INC. GIMOTI (Drug) Food and Beverage In-kind items and services $13.50 General
Category: Gastroenterology
11/14/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $88.24 General
Category: GASTROENTEROLOGY
11/13/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $36.68 General
Category: GASTROENTEROLOGY
11/12/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $1.29 General
Category: GASTROENTEROLOGY
11/11/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $25.18 General
Category: IMMUNOLOGY
11/07/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $24.11 General
Category: Immunology
11/05/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $17.67 General
Category: INTERNAL MEDICINE
11/01/2024 PFIZER INC. VELSIPITY (Drug) Travel and Lodging In-kind items and services $1,515.75 General
Category: INFLAMMATION;PAIN
10/30/2024 PFIZER INC. VELSIPITY (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,125.00 General
Category: INFLAMMATION;PAIN

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 395 414 $104,103 $27,790
2022 7 405 430 $85,593 $30,487
2021 6 420 455 $80,295 $33,464
2020 7 332 352 $51,468 $20,938
Total Patients
1,552
Total Services
1,651
Medicare Billing
$112,679
Procedure Codes
29

All Medicare Procedures & Services

29 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 164 181 $47,666 $13,062 27.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 57 57 $19,620 $5,607 28.6%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 29 30 $11,064 $3,110 28.1%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 48 48 $11,107 $2,624 23.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 37 37 $6,880 $1,655 24.1%
76981 Ultrasound scan of organ tissue for measuring elasticity Office 2023 12 12 $2,370 $779.94 32.9%
99202 New patient office or other outpatient visit, 15-29 minutes Office 2023 18 18 $2,672 $464.00 17.4%
98968 Telephone medical discussion provided by nonphysician professional, 21-30 minutes Office 2023 16 16 $1,600 $285.22 17.8%
98967 Telephone medical discussion provided by nonphysician professional, 11-20 minutes Office 2023 14 15 $1,125 $203.97 18.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 153 173 $33,590 $12,127 36.1%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 56 60 $16,255 $6,594 40.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 63 63 $16,417 $6,153 37.5%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 54 54 $9,329 $2,975 31.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 37 38 $5,221 $1,371 26.3%
99202 New patient office or other outpatient visit, 15-29 minutes Office 2022 30 30 $3,532 $669.97 19.0%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2022 12 12 $1,248 $596.73 47.8%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 160 187 $32,343 $14,441 44.7%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 63 63 $15,930 $6,363 39.9%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 74 74 $12,382 $4,563 36.9%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 36 39 $9,093 $3,716 40.9%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 71 76 $8,736 $3,609 41.3%
99202 New patient outpatient visit, total time 15-29 minutes Office 2021 16 16 $1,811 $771.68 42.6%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 121 138 $19,734 $8,537 43.3%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 48 48 $10,704 $4,536 42.4%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 68 69 $6,624 $2,689 40.6%

About Gabriella Mccarty, NP-C

Gabriella Mccarty, NP-C is a Adult Health healthcare provider based in Westlake, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508896754.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Gabriella Mccarty, NP-C has received a total of $140,804 in payments from pharmaceutical and medical device companies, with $72,510 received in 2024. These payments were reported across 541 transactions from 35 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($57,709).

As a Medicare-enrolled provider, Mccarty has provided services to 1,552 Medicare beneficiaries, totaling 1,651 services with total Medicare billing of $112,679. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.

Practice Information

  • Specialty Adult Health
  • Location Westlake, OH
  • Active Since 07/04/2006
  • Last Updated 01/23/2024
  • Taxonomy Code 363LA2200X
  • Entity Type Individual
  • NPI Number 1508896754

Products in Payments

  • VOQUEZNA (Drug) $21,393
  • VELSIPITY (Drug) $14,311
  • ZEPOSIA (Drug) $13,172
  • OMVOH (Drug) $12,885
  • GIMOTI (Drug) $8,749
  • OCALIVA (Drug) $8,520
  • TREMFYA (Drug) $6,288
  • XELJANZ (Drug) $6,062
  • STELARA (Biological) $4,613
  • REZDIFFRA (Drug) $4,169
  • DUPIXENT (Biological) $3,653
  • SKYRIZI (Biological) $3,531
  • RINVOQ (Biological) $3,515
  • HUMIRA (Biological) $2,477
  • RELISTOR (Drug) $2,312
  • XIFAXAN (Drug) $2,013
  • IBSRELA (Drug) $1,048
  • EOHILIA (Drug) $884.93
  • ENTYVIO (Biological) $325.67
  • DIFICID (Drug) $103.73

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Adult Health Doctors in Westlake